In this role, the AFRM will work closely with the Field Reimbursement Managers (FRMs) to assist with providing reimbursement support to customers and Account Executives for all StimLabs products.
\n ESSENTIAL DUTIES AND RESPONSIBILITIESSupport the FRM team to enhance access and fulfillment related to StimLabs products.Foster effective communication across various departments, including Market Access, Marketing, Customer Service, Accounting, and Field Sales.Contribute to both long-term and short-term strategic planning, executing necessary tactics in a fast- paced environment.Demonstrate comprehensive knowledge of reimbursement and market access for StimLabs' entire product portfolio.Assist FRM's as needed by educating new and existing customers on product reimbursement, including billing, coding, claims submission, national and local coverage policies, and best practices for clinicaldocumentation.Collaborate with sales, market access, and insurance verification teams to proactively monitor reimbursement activities and address reimbursement challenges.Support team members in identifying, understanding, and overcoming patient access and fulfillment obstacles, with an emphasis on reimbursement knowledge across different service sites.Perform related duties as assigned MINIMUM QUALIFICATIONS (KNOWLEDGE, SKILLS, AND ABILITIES)Strong understanding of healthcare reimbursement processes and market access strategies.Excellent communication and interpersonal skills.Ability to work effectively in a team-oriented and fast-paced environment.Experience in customer education and support related to healthcare products.Familiarity with coding practices and claims submission processes.Proactive problem-solving skills and a commitment to supporting both the team and customers.
\nStimLabs was founded in 2015 with a desire to advance the state of regenerative medicine. In pursuit of this goal, StimLabs has gathered exceptional scientific and clinical minds to develop and commercialize new bioactive technologies. While current technologies in medical devices, pharmaceuticals, and tissue banking provide useful products, StimLabs believes in the untapped synergy at the intersection of these independent domains. In the first steps towards this vision, StimLabs has launched a suite of next-generation amniotic-derived products. The success of these initial offerings has created a foundation on which StimLabs will continue building the future of regenerative medicine.